Aclaris Therapeutics shares owned by Cambridge Investment Research Advisors
Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by Cambridge Investment Research Advisors
from 13F filings
Historical chart of Cambridge Investment Research Advisors investment in Aclaris Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aclaris Therapeutics held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aclaris Therapeutics by Cambridge Investment Research Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $52k | 42k | 1.24 |
| 2023-12-31 | $44k | 42k | 1.05 |
| 2023-09-30 | $105k | 15k | 6.85 |
| 2023-06-30 | $159k | 15k | 10.37 |
| 2023-03-31 | $124k | 15k | 8.08 |
| 2022-12-31 | $242k | 15k | 15.78 |
| 2022-09-30 | $245k | 16k | 15.77 |
| 2022-06-30 | $214k | 15k | 13.95 |
| 2022-03-31 | $264k | 15k | 17.21 |
| 2021-12-31 | $223k | 15k | 14.54 |
| 2021-09-30 | $276k | 15k | 17.99 |
| 2021-06-30 | $258k | 15k | 17.55 |
| 2021-03-31 | $370k | 15k | 25.17 |
| 2020-12-31 | $290k | 45k | 6.48 |
| 2020-09-30 | $115k | 45k | 2.57 |
| 2020-06-30 | $72k | 45k | 1.61 |
| 2020-03-31 | $46k | 45k | 1.03 |
| 2019-12-31 | $84k | 45k | 1.88 |
| 2019-09-30 | $48k | 45k | 1.07 |